Recently, emerging physiological roles of USP30 in neurodegenerative diseases, cancer, and pulmonary disorders have been reported, and mechanistic studies indicated the therapeutic potential of USP30 inhibitors. This evidence concerns the gene USP30 and neurodegenerative disease.